Sutep Jaruratanasirikul1, Somchai Sriwiriyajan. 1. Department of Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkla 90110, Thailand. jasutep@ratree.psu.ac.th
Abstract
OBJECTIVES: The aim of this study was to compare the pharmacokinetics and pharmacodynamics of meropenem when administered by 3 h infusion or bolus injection regimens. PATIENTS AND METHODS: The study was a randomized three-way crossover study with a 1 week wash-out period in 12 healthy volunteers. Each subject received a single dose of meropenem in three regimens: (i) bolus injection of 1 g meropenem; (ii) 3 h infusion of 1 g meropenem; and (iii) 3 h infusion of 0.5 g meropenem. RESULTS: Following bolus injection of 1 g meropenem, the mean +/- s.d. percentages of the t > MIC of 4, 2 and 1 mg/L were 42.50 +/- 6.20%, 54.38 +/- 7.64% and 67.04 +/- 8.47% of an 8 h dosing interval, respectively. For the 3 h infusion of 1 g meropenem, the percentages of the t > MIC of 4, 2 and 1 mg/L were 59.27 +/- 7.34%, 71.97 +/- 8.63% and 86.07 +/- 9.41% of an 8 h dosing interval, respectively. For the 3 h infusion of 0.5 g meropenem, the percentages of the t > MIC of 4, 2 and 1 mg/L were 47.27 +/- 5.34%, 59.36 +/- 6.60% and 71.44 +/- 8.45% of an 8 h dosing interval, respectively. CONCLUSIONS: We conclude that a 3 h infusion of 0.5 g or 1 g of meropenem both give greater values for t > MIC than a 1 g bolus and that intermittent infusion may be a useful mode of administration in tropical countries where drug instability may prevent the use of continuous infusion.
RCT Entities:
OBJECTIVES: The aim of this study was to compare the pharmacokinetics and pharmacodynamics of meropenem when administered by 3 h infusion or bolus injection regimens. PATIENTS AND METHODS: The study was a randomized three-way crossover study with a 1 week wash-out period in 12 healthy volunteers. Each subject received a single dose of meropenem in three regimens: (i) bolus injection of 1 g meropenem; (ii) 3 h infusion of 1 g meropenem; and (iii) 3 h infusion of 0.5 g meropenem. RESULTS: Following bolus injection of 1 g meropenem, the mean +/- s.d. percentages of the t > MIC of 4, 2 and 1 mg/L were 42.50 +/- 6.20%, 54.38 +/- 7.64% and 67.04 +/- 8.47% of an 8 h dosing interval, respectively. For the 3 h infusion of 1 g meropenem, the percentages of the t > MIC of 4, 2 and 1 mg/L were 59.27 +/- 7.34%, 71.97 +/- 8.63% and 86.07 +/- 9.41% of an 8 h dosing interval, respectively. For the 3 h infusion of 0.5 g meropenem, the percentages of the t > MIC of 4, 2 and 1 mg/L were 47.27 +/- 5.34%, 59.36 +/- 6.60% and 71.44 +/- 8.45% of an 8 h dosing interval, respectively. CONCLUSIONS: We conclude that a 3 h infusion of 0.5 g or 1 g of meropenem both give greater values for t > MIC than a 1 g bolus and that intermittent infusion may be a useful mode of administration in tropical countries where drug instability may prevent the use of continuous infusion.
Authors: Jürgen B Bulitta; Martina Kinzig; Verena Jakob; Ulrike Holzgrabe; Fritz Sörgel; Nicholas H G Holford Journal: Br J Clin Pharmacol Date: 2010-11 Impact factor: 4.335
Authors: Dagan O Lonsdale; Emma H Baker; Karin Kipper; Charlotte Barker; Barbara Philips; Andrew Rhodes; Mike Sharland; Joseph F Standing Journal: Br J Clin Pharmacol Date: 2018-11-26 Impact factor: 4.335
Authors: Finbarr Foy; Giuseppe Luna; Jorge Martinez; Zach Nizich; Jason Seet; Katie Lie; Bruce Sunderland; Petra Czarniak Journal: Drug Des Devel Ther Date: 2019-08-01 Impact factor: 4.162